USA flag logo/image

An Official Website of the United States Government

METALLIC NANOSENSOR MATRIX WITH ENHANCED FLUORESCENCE

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
60046
Program Year/Program:
2002 / SBIR
Agency Tracking Number:
CA097569
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
MICROCOSM, INC.
MICROCOSM, INC. 6430 Dobbin Road, Suite B COLUMBIA, MD 21045
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2002
Title: METALLIC NANOSENSOR MATRIX WITH ENHANCED FLUORESCENCE
Agency: HHS
Contract: 1R43CA097569-01
Award Amount: $399,915.00
 

Abstract:

DESCRIPTION (provided by applicant): Fluorescence is a dominant technology in medical testing, drug discovery, biotechnology and cellular imaging. There is demand for better fluorescent agents in terms of intensity, spectral range, functionality, photostability and phototoxicity. Recent trends in analytical and material sciences drive devices smaller and faster toward molecular level sensing. At this level, sensitive detection is a major issue.This research promises to provide nanoscale and molecular sensing with simultaneous dramatic increases in fluorescence signal to noise ratio. The sensing technology relies on the interaction of light with metallic nanoparticles such as silver and gold colloids resulting in remarkably high increases in fluorescence intensity of nearby fluorophores of up to 10 Million-fold. The research in development of nanosensors will be focused on fabrication of multifunctional composite nano-sized particles with fluorescent probes. The sensing elements will be constructed using silver and silica nanometer sized colloids combined with fluorescent probes. To demonstrate feasibility of the nanosensors, probes for pH and Ca2+ measurements will be used.Several modern optical techniques will be used to evaluate effects of fluorophore-metal surface interactions including laser scanning, two-photon excitation, and lifetime imaging microscopy. Software will be developed for rapid acquisition and image analysis of 2D and 3D nanosensors. The result of Phase I will be a basis of knowledge sufficient to permit prototype sensor fabrication and continued development in Phase II. Probe-metal colloid composites will significantly improve detection and analysis of biologically relevant analytes in samples including whole blood, saliva, and other body fluids. These novel sensors with improved intensities and photostability can be used with or without imaging optics. Due to the predicted large enhancement in fluorescence intensity, we envision the future development of field deployable biosensors to rapidly detect environmental infectious agents with sensitivity and specificity approaching if not surpassing laboratory procedures.

Principal Investigator:

Henry K. Szmacinski
3017252775
HENRYKS@MICROCOSM.COM

Business Contact:

Wayne Moore
3017252775
WAYNE@MICROCOSM.COM
Small Business Information at Submission:

MICROCOSM, INC.
MICROCOSM, INC. 9140 GUILFORD RD, STE O COLUMBIA, MD 21046

EIN/Tax ID: 521859225
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No